Breast Cancer

Metastatic Left Breast Carcinoma

Female, 37 years

Patient Internal ID: 854138860

ICD-10 code

C50.5 Malignant Neoplasm of Lower Outer Quadrant of Breast

Diagnosis (Incl. Metastases/Stage) and Year

March 2021
Carcinoma of Left Breast ypT2ypN1aM0 G3 LVI-2 ER (-), PR (-), HER2-Negative, Ki67-90% Stage IIB.
Unverified Nodules in Lungs.

Previous Treatment

Chemotherapy (Carboplatin + Paclitaxel), Chemotherapy (Adriamycin and Cyclophosphamide), Surgery,
Radiation Therapy, Chemotherapy (Capecitabine).

Prognosis and Survival Expectation

The prognosis of Triple-Negative Breast Cancer is often poor with lower survival rates and a high risk of recurrence. The 5-year relative survival rates for Triple-Negative Regional Breast Cancer are 66%.

Treatment Provided

Autologous DCV (5 doses) over a period of 4 months. Additionally, the patient received Allogeneic Umbilical Cord Blood Derived NK cells (12 doses) over a period of 11 months and  Immunostimulation of Interferon (IFN) β and Tumor Necrosis Factor (TNF).

Patient Survival/Condition and Year
Date of Review: 06/03/2024

The patient has survived for 36 months since the diagnosis with no sign of disease progression. She continues with regular follow-ups. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy, Surgery and Radiation Therapy, has led to cancer remission.